3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
4
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large-Cell, Anaplastic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Interventions
Cyclophosphamide
8
fludarabine
5
zanubrutinib
2
cemiplimab
2
Vincristine
2
Specimen Handling
2
Rituximab
2
Prednisone
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Etoposide
2
Doxorubicin
2
Cell- and Tissue-Based Therapy
2
tafasitamab
1
sodium-iodide symporter
1
selinexor
1
ruxolitinib
1
pomalidomide
1
polatuzumab vedotin
1
pirtobrutinib
1
obinutuzumab
1
glofitamab
1
etoposide phosphate
1
blinatumomab
1
X-Rays
1
Sirolimus
1
Photons
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Brentuximab Vedotin
×
30 days
×
Clear all
No trials found.